92 related articles for article (PubMed ID: 18261135)
21. Giant recurrent pyogenic granuloma on the face with satellitosis responsive to systemic steroids.
Tursen U; Demirkan F; Ikizoglu G
Clin Exp Dermatol; 2004 Jan; 29(1):40-1. PubMed ID: 14723719
[TBL] [Abstract][Full Text] [Related]
22. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children.
Mashiah J; Hadj-Rabia S; Slodownik D; Harel A; Sprecher E; Kutz A
J Dermatol; 2019 Mar; 46(3):245-248. PubMed ID: 30593715
[TBL] [Abstract][Full Text] [Related]
24. Intravascular pyogenic granuloma arising in an acquired arteriovenous malformation: report of a case and review of the literature.
Hung CH; Kuo HW; Chiu YK; Huang PH
Dermatol Surg; 2004 Jul; 30(7):1050-3. PubMed ID: 15209800
[TBL] [Abstract][Full Text] [Related]
25. Topical imiquimod for recalcitrant facial flat warts.
Schwab RA; Elston DM
Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
[TBL] [Abstract][Full Text] [Related]
26. Recurrent pyogenic granulomas: a form of lobular capillary hemangioma.
Eng AM; Hong HY
Cutis; 1993 Aug; 52(2):101-3. PubMed ID: 8404014
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
[TBL] [Abstract][Full Text] [Related]
28. Imiquimod 5% cream for actinic keratosis.
Perras C
Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
[No Abstract] [Full Text] [Related]
31. Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness.
Campione E; Paternò EJ; Diluvio L; Orlandi A; Bianchi L; Chimenti S
J Dermatolog Treat; 2009; 20(1):10-3. PubMed ID: 18651299
[TBL] [Abstract][Full Text] [Related]
32. Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3.
Le T; Hicks W; Menard C; Hopkins L; Fung MF
Am J Obstet Gynecol; 2006 Feb; 194(2):377-80. PubMed ID: 16458632
[TBL] [Abstract][Full Text] [Related]
33. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
[TBL] [Abstract][Full Text] [Related]
34. Erythroplasia of Queyrat treated with imiquimod 5% cream.
Micali G; Nasca MR; De Pasquale R
J Am Acad Dermatol; 2006 Nov; 55(5):901-3. PubMed ID: 17052503
[TBL] [Abstract][Full Text] [Related]
35. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
Dendorfer M; Oppel T; Wollenberg A; Prinz JC
Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
[TBL] [Abstract][Full Text] [Related]
36. Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod.
Montes-De-Oca-Sánchez G; Tirado-Sánchez A; García-Ramírez V
J Dermatolog Treat; 2006; 17(5):319-20. PubMed ID: 17092865
[TBL] [Abstract][Full Text] [Related]
37. A Shot of Alcohol May be the Answer to Persistent Pyogenic Granulomas.
Ilkovitch D; Sam H
Dermatol Surg; 2016 Sep; 42(9):1119-20. PubMed ID: 27243135
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
[TBL] [Abstract][Full Text] [Related]
40. Recalcitrant molluscum contagiosum in an HIV-afflicted male treated successfully with topical imiquimod.
Brown CW; O'Donoghue M; Moore J; Tharp M
Cutis; 2000 Jun; 65(6):363-6. PubMed ID: 10879304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
